GLP-1 drugs: what Montana Medicaid paid

Q: Does a paid prescription mean Montana Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Montana Medicaid shows a published payment figure for 5 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Montana Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Montana Medicaid’s payment record shows

In 2026Q1, the product Montana Medicaid paid for most often was Ozempic®, at 3,923 prescriptions¹⁹ of the 4,801 to 4,900^1,7,13,19,37 across all 8 products, or 82 percent of the published count.

Montana Medicaid itself reimbursed at least $4,835,012 for these products in the quarter, about $1,009 per prescription. Pharmacies were paid $4,867,558 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,313.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Montana Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Montana Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Montana Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Montana Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	at least 40¹	<1%	$42,510	$42,510	$1,063
tirzepatideMounjaro®	Fee-for-service	669⁷	14%	$713,536	$721,628	$1,067
semaglutideWegovy®	Fee-for-service	at least 77¹³	2%	$101,086	$101,086	$1,313
semaglutideOzempic®	Fee-for-service	at least 3,923¹⁹	82%	$3,923,504	$3,947,959	$1,000
semaglutideRybelsus®	Fee-for-service	Withheld	n/a	Not published	Not published	Not published
liraglutideSaxenda®	Not published	No row	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	81³⁷	2%	$54,375	$54,375	$671
liraglutideliraglutide (generic)	Fee-for-service	Withheld	n/a	Not published	Not published	Not published

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 81 against 1,341. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 25.2 to 25.7 prescriptions per thousand people enrolled in Montana Medicaid, on an average of 190,341 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 8 of the 168 product-quarters it holds a row for here, which is 5 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Across every quarter on file, the federal record holds no row at all for Saxenda®. That is an absence in the file rather than a refusal by Montana Medicaid: no prescription was reported, and the reason is not published here.

Ozempic® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Montana Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Montana Medicaid paid for each product, quarter by quarter

Prescriptions Montana Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²Withheld3 of 3 product codes withheld	at least 25 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$26,903 paid	at least 11 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$11,639 paid	at least 40 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$42,510 paid
tirzepatideMounjaro®range 162 to 755, down 50 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld4 of 4 product codes withheld	at least 28 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$27,083 paid	at least 42 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$43,054 paid	at least 106 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$114,015 paid	162 paid prescriptions in the quarter (2023Q3)¹⁰Count$162,773 paid	224 paid prescriptions in the quarter (2023Q4)¹⁰Count$220,935 paid	304 paid prescriptions in the quarter (2024Q1)⁹Count$304,295 paid	348 paid prescriptions in the quarter (2024Q2)⁹Count$355,511 paid	501 paid prescriptions in the quarter (2024Q3)⁹Count$506,397 paid	535 paid prescriptions in the quarter (2024Q4)⁹Count$550,530 paid	662 paid prescriptions in the quarter (2025Q1)⁸Count$691,483 paid	755 paid prescriptions in the quarter (2025Q2)⁸Count$786,449 paid	732 paid prescriptions in the quarter (2025Q3)⁸Count$760,205 paid	719 paid prescriptions in the quarter (2025Q4)⁸Count$744,799 paid	669 paid prescriptions in the quarter (2026Q1)⁷Count$713,536 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	at least 27 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$35,168 paid	at least 26 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$34,118 paid	at least 57 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$74,704 paid	at least 44 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$57,665 paid	at least 26 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$34,048 paid	at least 77 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$101,086 paid
semaglutideOzempic®range 383 to 3,895	383 paid prescriptions in the quarter (2021Q1)²⁴Count$333,774 paid	462 paid prescriptions in the quarter (2021Q2)²⁴Count$413,014 paid	529 paid prescriptions in the quarter (2021Q3)²⁴Count$476,511 paid	628 paid prescriptions in the quarter (2021Q4)²⁴Count$576,912 paid	at least 750 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$705,043 paid	at least 830 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$803,236 paid	at least 1,082 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,026,527 paid	at least 1,422 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$1,365,107 paid	1,841 paid prescriptions in the quarter (2023Q1)²²Count$1,826,819 paid	at least 2,310 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$2,247,213 paid	at least 2,597 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$2,383,438 paid	at least 2,590 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$2,400,665 paid	at least 2,714 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$2,539,042 paid	at least 3,406 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$3,215,153 paid	3,895 paid prescriptions in the quarter (2024Q3)²¹Count$3,654,769 paid	at least 3,578 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$3,364,690 paid	at least 3,542 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$3,415,509 paid	at least 3,849 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$3,716,021 paid	at least 3,938 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$3,818,061 paid	at least 3,934 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$3,810,004 paid	at least 3,923 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$3,923,504 paid
semaglutideRybelsus®range 60 to 62	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁰Withheld3 of 3 product codes withheld	at least 28 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$24,798 paid	at least 39 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$37,186 paid	at least 43 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$38,993 paid	at least 33 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$30,124 paid	at least 40 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$40,687 paid	at least 41 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$42,411 paid	at least 44 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$47,779 paid	at least 46 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$52,483 paid	at least 51 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$56,560 paid	at least 32 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$27,385 paid	62 paid prescriptions in the quarter (2023Q4)²⁸Count$53,948 paid	at least 74 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$67,431 paid	at least 68 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$62,155 paid	at least 65 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$58,537 paid	at least 58 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$50,970 paid	at least 40 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$35,785 paid	60 paid prescriptions in the quarter (2025Q2)²⁶Count$54,568 paid	at least 37 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$35,299 paid	at least 24 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$23,012 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable²⁵Withheld2 of 2 product codes withheld
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 57 to 1,468, up 24 on the quarter before	1,341 paid prescriptions in the quarter (2021Q1)⁴²Count$1,239,474 paid	1,468 paid prescriptions in the quarter (2021Q2)⁴²Count$1,380,031 paid	1,454 paid prescriptions in the quarter (2021Q3)⁴²Count$1,393,777 paid	1,296 paid prescriptions in the quarter (2021Q4)⁴²Count$1,284,304 paid	1,165 paid prescriptions in the quarter (2022Q1)⁴¹Count$1,223,395 paid	1,045 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,100,385 paid	928 paid prescriptions in the quarter (2022Q3)⁴¹Count$992,694 paid	927 paid prescriptions in the quarter (2022Q4)⁴¹Count$1,007,390 paid	897 paid prescriptions in the quarter (2023Q1)⁴⁰Count$1,015,305 paid	759 paid prescriptions in the quarter (2023Q2)⁴⁰Count$823,883 paid	699 paid prescriptions in the quarter (2023Q3)⁴⁰Count$686,219 paid	645 paid prescriptions in the quarter (2023Q4)⁴⁰Count$608,617 paid	485 paid prescriptions in the quarter (2024Q1)³⁹Count$376,853 paid	426 paid prescriptions in the quarter (2024Q2)³⁹Count$306,038 paid	240 paid prescriptions in the quarter (2024Q3)³⁹Count$168,545 paid	173 paid prescriptions in the quarter (2024Q4)³⁹Count$129,937 paid	137 paid prescriptions in the quarter (2025Q1)³⁸Count$86,238 paid	67 paid prescriptions in the quarter (2025Q2)³⁸Count$43,836 paid	69 paid prescriptions in the quarter (2025Q3)³⁸Count$45,420 paid	57 paid prescriptions in the quarter (2025Q4)³⁸Count$38,432 paid	81 paid prescriptions in the quarter (2026Q1)³⁷Count$54,375 paid
liraglutideliraglutide (generic)range 99 to 136	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	136 paid prescriptions in the quarter (2024Q3)⁴⁵Count$85,607 paid	109 paid prescriptions in the quarter (2024Q4)⁴⁵Count$67,699 paid	99 paid prescriptions in the quarter (2025Q1)⁴⁴Count$64,231 paid	at least 100 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$63,138 paid	at least 38 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$27,247 paid	at least 21 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$10,949 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable⁴³Withheld6 of 6 product codes withheld

What this page cannot tell you

Whether Montana Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Montana in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, MT
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND 5", "suppression_used": "false", "number_of_prescriptions": "15"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, MT
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "14"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, MT
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like ZEPBOUND%, state MT, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, MT
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like ZEPBOUND%, state MT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, MT
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like ZEPBOUND%, state MT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, MT
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like ZEPBOUND%, state MT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, MT
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "166"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, MT
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "MOUNJARO 7", "suppression_used": "false", "number_of_prescriptions": "165"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, MT
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "MOUNJARO 7", "suppression_used": "false", "number_of_prescriptions": "144"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, MT
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "59"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, MT
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, MT
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like MOUNJARO%, state MT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, MT
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "29"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, MT
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "33"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, MT
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "15"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, MT
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like WEGOVY%, state MT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, MT
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like WEGOVY%, state MT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, MT
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like WEGOVY%, state MT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, MT
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "1539"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, MT
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "1500"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, MT
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1407"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, MT
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2023", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1143"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, MT
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "741"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, MT
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "324"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, MT
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, MT
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "28"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, MT
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "37"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, MT
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "34"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, MT
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "32"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, MT
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2021", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "25"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, MT
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like SAXENDA%, state MT, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, MT
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like SAXENDA%, state MT, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, MT
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like SAXENDA%, state MT, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, MT
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like SAXENDA%, state MT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, MT
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like SAXENDA%, state MT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, MT
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like SAXENDA%, state MT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, MT
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, MT
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "99"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, MT
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "297"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, MT
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "570"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, MT
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2022", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "706"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, MT
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2021", "quarter": "3", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "862"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, MT
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state MT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, MT
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state MT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "43"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, MT
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state MT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "84"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, MT
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state MT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like LIRAGLUTID%, state MT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, MT
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state MT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like LIRAGLUTID%, state MT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, MT
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state MT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MT", "product_name": "product_name like LIRAGLUTID%, state MT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 31 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 17 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Montana Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.